{"id":"https://openalex.org/W4361815010","doi":"https://doi.org/10.1158/1078-0432.22482021","title":"Supplementary figure 9 from Anti\u2013PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8+ T cells","display_name":"Supplementary figure 9 from Anti\u2013PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8+ T cells","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361815010","doi":"https://doi.org/10.1158/1078-0432.22482021"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22482021","doi":"https://doi.org/10.1158/1078-0432.22482021","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22482021","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22482021","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080890610","display_name":"Maud Rijnders","orcid":"https://orcid.org/0000-0002-1552-0813","observed_orcids":["https://orcid.org/0000-0002-1552-0813"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maud Rijnders","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082499429","display_name":"Hayri Emrah Balcioglu","orcid":"https://orcid.org/0000-0002-0225-0180","observed_orcids":["https://orcid.org/0000-0002-0225-0180"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hayri E. Balcioglu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0225-0180","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081043422","display_name":"Debbie G. J. Robbrecht","orcid":"https://orcid.org/0000-0003-2490-9991","observed_orcids":["https://orcid.org/0000-0003-2490-9991"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Debbie G.J. Robbrecht","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2490-9991","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085281469","display_name":"Astrid A.M. Oostvogels","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Astrid A.M. Oostvogels","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054947642","display_name":"Rebecca Wijers","orcid":"https://orcid.org/0009-0002-6129-3612","observed_orcids":["https://orcid.org/0009-0002-6129-3612"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rebecca Wijers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081011064","display_name":"Maureen J.B. Aarts","orcid":"https://orcid.org/0000-0002-6381-1500","observed_orcids":["https://orcid.org/0000-0002-6381-1500"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maureen J.B. Aarts","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047950538","display_name":"Paul Hamberg","orcid":"https://orcid.org/0000-0002-8223-0250","observed_orcids":["https://orcid.org/0000-0002-8223-0250"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Hamberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083000708","display_name":"Geert J.L.H. van Leenders","orcid":"https://orcid.org/0000-0003-2176-9102","observed_orcids":["https://orcid.org/0000-0003-2176-9102"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Geert J.L.H. van Leenders","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2176-9102","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"J. Alberto Nakauma-Gonz\u00e1lez","orcid":"https://orcid.org/0000-0002-9153-4280","observed_orcids":["https://orcid.org/0000-0002-9153-4280"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Alberto Nakauma-Gonz\u00e1lez","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9153-4280","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090455186","display_name":"Jens Voortman","orcid":"https://orcid.org/0000-0001-8309-2614","observed_orcids":["https://orcid.org/0000-0001-8309-2614"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jens Voortman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8309-2614","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063553660","display_name":"Hans M. Westgeest","orcid":"https://orcid.org/0000-0002-5735-3638","observed_orcids":["https://orcid.org/0000-0002-5735-3638"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hans M. Westgeest","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5735-3638","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080250383","display_name":"Joost L. Boormans","orcid":"https://orcid.org/0000-0002-5127-0436","observed_orcids":["https://orcid.org/0000-0002-5127-0436"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joost L. Boormans","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041610986","display_name":"Ronald de Wit","orcid":"https://orcid.org/0000-0002-1954-090X","observed_orcids":["https://orcid.org/0000-0002-1954-090X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ronald de Wit","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1954-090X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078332643","display_name":"Martijn P. Lolkema","orcid":"https://orcid.org/0000-0003-0466-2928","observed_orcids":["https://orcid.org/0000-0003-0466-2928"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martijn P. Lolkema","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0466-2928","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009376752","display_name":"Astrid A.M. van der Veldt","orcid":"https://orcid.org/0000-0003-0446-1907","observed_orcids":["https://orcid.org/0000-0003-0446-1907"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Astrid A.M. van der Veldt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5069775632","display_name":"Reno Debets","orcid":"https://orcid.org/0000-0002-3649-807X","observed_orcids":["https://orcid.org/0000-0002-3649-807X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Reno Debets","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3649-807X","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.016499999910593033,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.953000009059906},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.8579999804496765},{"id":"https://openalex.org/keywords/metastatic-urothelial-carcinoma","display_name":"metastatic urothelial carcinoma","score":0.9200000166893005},{"id":"https://openalex.org/keywords/t-helper-type-1-cells","display_name":"T helper type 1 cells","score":0.8140000104904175},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.6690000295639038},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7080000042915344}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7953916192054749},{"id":"https://openalex.org/C3020745361","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Urothelial cancer","level":4,"score":0.6003348231315613},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.529866635799408},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.478355348110199},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.4730105698108673},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.45967724919319153},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3795856833457947},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33292242884635925},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.33164358139038086},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21384641528129578},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.21184515953063965},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.1367568075656891}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22482021","doi":"https://doi.org/10.1158/1078-0432.22482021","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22482021","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22482021","doi":"https://doi.org/10.1158/1078-0432.22482021","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22482021","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3204056788","https://openalex.org/W4361817621","https://openalex.org/W3034982015","https://openalex.org/W2762020624","https://openalex.org/W7163473497","https://openalex.org/W7163477170","https://openalex.org/W3031149108","https://openalex.org/W3047290082","https://openalex.org/W7163496308","https://openalex.org/W4236595554"],"abstract_inverted_index":{"Proposed":[0],"mechanism":[1],"of":[2,4],"action":[3],"pembrolizumab":[5],"in":[6],"mUC":[7],"patients":[8]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-04-05T00:00:00"}